Market Indices
Latest News
 |
from Oppenheimer issued a price target of $8.00 for July 9, 2026 CNTB 14.19% |
| ||
| ||
| ||
|
Price Targets
from Oppenheimer issued a price target of $8.00 for CNTB on 2026-07-09 11:57:01.The adjusted price target was set to $8.00.At the time of the announcement, CNTB was...
July 9, 2026 CNTB 14.19%
Li Watsek from Cantor Fitzgerald issued a price target of $17.00 for IMRX on 2026-07-08 10:51:57.The adjusted price target was set to $17.00.At the time of the announcement,
July 8, 2026 IMRX -2.08%
from Needham issued a price target of $19.00 for ONDS on 2026-07-07 12:51:10.The adjusted price target was set to $19.00.At the time of the announcement, ONDS was...
July 7, 2026 ONDS 1.97%
from RBC Capital issued a price target of $14.00 for VSTM on 2026-07-07 11:31:28.The adjusted price target was set to $14.00.At the time of the announcement, VSTM...
July 7, 2026 VSTM 2.26%
Market Movers
| Top Gainers (%) | |||||||||||||||||||
| WRAP Wrap Technologies, Inc. | 2.44
53.46% | ||||||||||||||||||
| TMCWW TMC the metals company In | 0.09
19.95% | ||||||||||||||||||
| JSPRW Jasper Therapeutics, Inc. | 0.01
19.44% | ||||||||||||||||||
| AP Ampco-Pittsburgh Corp. | 8.28
15.48% | ||||||||||||||||||
| CNTB Connect Biopharma Holding | 2.54
14.19% | ||||||||||||||||||
| LRMR Larimar Therapeutics, Inc | 4.08
13.02% | ||||||||||||||||||
| BDSX Biodesix, Inc. | 22.42
11.28% | ||||||||||||||||||
| DWSN Dawson Geophysical Compan | 7.50
10.78% | ||||||||||||||||||
Annual/Quarterly Reports Summary
In a landscape marked by rapid technological advancements, the company saw a revenue increase of $1.4 million for the three months ending September 30, 2024, fueled by new licenses and...
November 6, 2024 AIP 5.76%
In a landscape of fluctuating revenues, the company celebrated a 25% revenue increase in Q3 2024, yet faced a 14% decline over nine months due to production challenges. Operating expenses...
November 6, 2024 EOSEW -34.96%
In a landscape marked by financial challenges, the company faced fluctuating revenues, with a notable 25% increase in Q3 2024 overshadowed by a 14% decline over nine months. Operating losses...
November 6, 2024 EOSE 3.66%
In a tale of growth and ambition, the company witnessed its revenue soar from $6.0 million to $13.9 million, fueled by partnerships with Acadia Pharmaceuticals. However, operating expenses, particularly in...
November 5, 2024 STOK 0.12%
In a transformative period, the company experienced a remarkable surge in revenue, driven by newly acquired oil and gas assets. Operating expenses showed notable trends, with a decrease in occupancy...
November 5, 2024 BSVN 0.68%